It has been reported that PMEPA1 could exacerbate triple-negative breast cancer (TNBC) tumor progression by increasing PTEN turnover and attenuating PTEN expression to promote the expression of atypical PI3K/AKT signaling. This evidence concerns the gene AKT1 and neoplasm.